华宝中证金融科技主题ETF（159851）基金经理为陈建华、曹旭辰。 截至发稿，陈建华累计任职时间12年282天，现任基金资产总规模155.33亿元，任职期间最佳基金回报 166.28%， 任职期间最差基金回报-49.65%。 曹旭辰累计任职时间128天，现任基金资产总规模220.62亿元，任职期间最佳基金回报91.15%， 任职期 间最差基金回报7.38%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 9月26日，格灵深瞳跌5.08%，截至发稿，报16.99元/股，成交1.23亿元，换手率2.73%，总市值44.00亿 元。 资料显示，北京格灵深瞳信息技术股份有限公司位于北京市海淀区东升科技园北街6号院中关村科学城· 东升科技园10号楼8层，成立日期2013年8月16日，上市日期2022年3月17日，公司主营业务涉及将先进 的计算机视觉技术和大数据分析技术与应用场景深度融合,提供面向城市管理、智慧金融、商业零售、 体育健康、轨交运维等领域的人工智 ...

Core Viewpoint - The company, Geling Deep Vision, has experienced fluctuations in its stock performance and financial metrics, indicating potential challenges in revenue generation and profitability [1][2]. Group 1: Stock Performance - On August 27, Geling Deep Vision's stock rose by 3.59%, with a trading volume of 397 million yuan [1]. - The financing buy-in amount on the same day was 41.45 million yuan, while the financing repayment was 49.10 million yuan, resulting in a net financing buy of -7.65 million yuan [1]. - As of August 27, the total balance of margin trading was 160 million yuan, which is 4.65% of the circulating market value, indicating a relatively low financing balance compared to the past year [1]. Group 2: Financial Performance - For the first half of 2025, Geling Deep Vision reported a revenue of 42.47 million yuan, reflecting a year-on-year decrease of 17.22% [2]. - The net profit attributable to the parent company was -79.85 million yuan, showing a year-on-year decline of 2.48% [2]. - As of June 30, 2025, the number of shareholders increased by 3.78% to 15,600, while the average circulating shares per person decreased by 3.65% to 12,131 shares [2]. Group 3: Company Overview - Geling Deep Vision, established on August 16, 2013, and listed on March 17, 2022, specializes in integrating advanced computer vision and big data analysis technologies into various applications [1]. - The company's main business revenue composition includes 58.58% from AI products, 26.46% from smart terminal products, and 14.95% from technical services and others [1]. - The company is located in Haidian District, Beijing, within the Zhongguancun Science City [1].

Core Insights - Pixel Cake launched a comprehensive "online + pixel cloud space + offline" ecosystem at the "All-round Creation" themed conference in Shanghai, featuring an integrated intelligent workflow and the new Pixel Cake 8.0 version [1][3] - The integrated intelligent workflow significantly reduces the time required for photography processes from three days to just three minutes, enhancing efficiency and meeting customer demands for rapid delivery [1] - The new Pixel Cake 8.0 version introduces five innovative features, including clothing change for ID photos and intelligent prop restoration, expanding the AI creative toolbox [3] Company Overview - Pixel Cake is a subsidiary of Xiamen Xiantian Technology Co., Ltd., focusing on the intelligent application of computer vision technology in creative design, providing commercial-grade intelligent imaging solutions for commercial photography [1] - The company aims to streamline the workflow in commercial photography, allowing for a more dynamic and engaging presentation of images through various templates and effects [1] Industry Trends - According to iResearch data, as of March and April this year, AI tool users accounted for 38% of domestic AI users, indicating a growing trend in AI adoption within the commercial photography sector [5] - The commercialization of AI in photography is driven by the need to control costs and increase revenue, with applications including AI retouching, virtual scene generation, and personalized style transfer [5]

Core Insights - By 2024, China's AI-related paper citation volume is expected to account for 40.2% of the global total, rapidly catching up to the United States at 42.9% [1][8] - The report titled "Scientific Intelligence White Paper 2025" analyzes the integration of AI and scientific research across seven major research fields, covering 28 directions and nearly 90 key issues [1] - The report highlights the dual promotion and deep integration of AI innovation and scientific research, termed "AI for Science" [1] Research Trends - The number of global AI journal papers has surged nearly threefold over the past decade, from 308,900 to 954,500, with an average annual growth rate of 14% [7] - The share of core AI fields, such as algorithms and machine learning, has decreased from 44% to 38%, while the share of scientific intelligence has increased by 6 percentage points, with an annual growth rate rising from 10% before 2020 to 19% after [7] - China’s AI publication volume increased from 60,100 in 2015 to 300,400 in 2024, representing 29% of the global total [7][8] Citation Impact - The citation volume of AI-related papers in the U.S. reached 302,200 in 2020, while China's citations rose from 10,300 in 2015 to 144,800 in 2020, surpassing the EU for the first time in 2021 [8] - By 2024, China is projected to account for 41.6% of global AI citations in patents, policy documents, and clinical trials, significantly leading the field [8] Country-Specific Trends - China has a leading position in the intersection of AI with earth and environmental sciences, and has surpassed in AI with mathematics, material sciences, and humanities since 2019 [9] - The U.S. and EU maintain advantages in AI and life sciences, with China ranking third in this area [9] - India shows significant progress across all fields, currently ranking third in earth and environmental sciences, engineering, and humanities [9]

Group 1 - Shenzhen Yipuson Technology Co., Ltd. and its subsidiaries have obtained a patent for a "robot control method and system based on computer vision technology," with the patent number CN119717884B, applied for on February 2025 [1] - Shenzhen Yipuson Technology Co., Ltd. was established in 2011, has a registered capital of 61.489 million RMB, and has participated in 127 bidding projects [1] - Shenzhen Yipuson Smart Health Technology Co., Ltd. was established in 2017, has a registered capital of 30 million RMB, and has participated in 126 bidding projects [1] Group 2 - Shenzhen Yipuson Biotechnology Co., Ltd. was established in 2017, has a registered capital of 10 million RMB, and has participated in 73 bidding projects [2] - Shenzhen Yipuson Technology Co., Ltd. holds 70 patents, while Shenzhen Yipuson Smart Health Technology Co., Ltd. holds 134 patents [1] - Shenzhen Yipuson Biotechnology Co., Ltd. has 42 administrative licenses [2]